Navigation Links
Global HER-2 Positive Breast Cancer Market 2015-2019 - Key Players are Celgene, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis & Sanofi

DUBLIN, Mar. 24, 2015 /PRNewswire/ --Research and Markets

( has announced the addition of the "Global HER-2 Positive Breast Cancer Market 2015-2019" report to their offering.

The analysts forecast the Global HER-2 Positive Breast Cancer market to grow at a CAGR of 9.90 percent over the period 2014-2019.

This report covers the present scenario and the growth prospects of the Global HER-2 Positive Breast Cancer Market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of targeted therapeutic agents, chemotherapeutic agents, and hormonal therapies that are used in the management of HER-2 positive breast cancer patients.

Increased public awareness is a key trend, which is expected to positively impact the growth of the market. Awareness and screening programs can help diagnose potential cases of breast cancer that would otherwise remain undetected till the late stages.

According to the report, the increase in the prevalence of breast cancer is a major driver, which is expected to affect the overall market growth in the next five years. With the growing incidence of breast cancer, more and more people are opting for the treatment regimen.

Further, the report states that late-stage diagnosis and expensive screening techniques pose a challenge to the market and have a negative impact on the market growth. Expensive screening techniques like mammography screening lead to poor response from patients.

Key Vendors

  • Celgene
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Novartis
  • Sanofi

Other Prominent Vendors

  • Actavis
  • Array BioPharma
  • Biocad
  • Biocon
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celltrion
  • Chugai Pharmaceutical
  • DARA BioSciences
  • EddingPharm
  • Eisai
  • Galena Biopharma
  • Halozyme Therapeutics
  • Hospira
  • Mylan
  • Oncothyreon
  • Pfizer
  • ProStrakan
  • Puma Biotechnology
  • Sun Pharmaceutical Industries
  • Synta Pharmaceuticals
  • Teva Pharmaceutical

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Disease Overview
  7. Pipeline Analysis
  8. Market Landscape
  9. Market Segmentation by Type of Therapy
  10. Market Segmentation by Molecule Type
  11. Market Segmentation by Route of Administration
  12. Geographical Segmentation
  13. Buying Criteria
  14. Market Growth Drivers
  15. Drivers and their Impact
  16. Market Challenges
  17. Impact of Drivers and Challenges
  18. Market Trends
  19. Trends and their Impact
  20. Vendor Landscape
  21. Key Vendor Analysis

For more information visit

Media Contact: Laura Wood , +353-1-481-1716,

SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Portages Biohaven enters into exclusive formulation agreement and global license with Catalent for lead product
2. Bynder and HubCast Forge Global Partnership for Transformative “Concept to Delivery” Solution
3. Global Engineered TCR and CAR Immunotherapeutics Analysis Report 2015
4. Greater Omaha Economic Development Partnership is VIP Sponsor for ITRA Global Spring Conference
5. Global Stem Cells Group to Hold Practical Adipose-Derived Stem Cell Harvesting, Isolation and Re-integration Training Course in Santa Cruz, Bolivia
6. Global Animal Genetics Market Worth Around $4 Billion by 2020
7. Two Global Directors Of Novartis And Alcon File Individual And Collective Gender Discrimination Case
8. Global Stem Cells Group to Participate in the 25th Argentine Congress of Aesthetic Medicine in Buenos Aires April 9-10, 2015
9. PositiveID Poised To Carve Out Its Share of the $27.4 Billion Global Polymerase Chain Reaction (PCR) Market in 2015: Analyst Report Issued by Small Cap IR
10. Global Molecular Diagnostics in Infectious Disease Testing Market Report 2014
11. Leaders of Major Brain Initiatives Convene for "Global Meeting of the Minds" at Israel Brain Technologies Braintech 2015 Conference in Tel Aviv
Post Your Comments:
(Date:6/26/2019)... ... ... Alice Branton today released research results from preclinical trials on the beneficial ... prove to be beneficial for treating Hypomagnesemia. , The preclinical trial shows:, ... , Over 142% increase in particle size , Over 3% ...
(Date:6/12/2019)... EGG HARBOR TOWNSHIP, N.J. (PRWEB) , ... June ... ... premier manufacturer of custom built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, ... partnership agreement with Shanghai Zillion has been signed. The agreement will grant exclusive ...
(Date:6/11/2019)... Calif. (PRWEB) , ... June 10, 2019 , ... ... today announced IOPP will add 80 of its scientific journals to DeepDyve’s rental ... physics-related content to DeepDyve’s continually expanding library of more than 20 million articles, ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... from human mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ ... a test on mice, MSC-EVs also increased the cells’ ability to lodge into ...
Breaking Biology Technology:
(Date:8/1/2019)... ... August 01, 2019 , ... John R. Freeman, CPA, has joined BioLabs as ... president of BioLabs, which provides premier co-working spaces for life science startups in the ... to forecast and manage growth,” says Fruehauf. “BioLabs has expanded to 10 locations in ...
(Date:7/26/2019)... (PRWEB) , ... July 26, 2019 , ... ... announce an exclusive interview with Helius Medical Technologies CEO Phil Deschamps to discuss ... , Helius Medical Technologies is a neurotech company in the medical ...
(Date:7/23/2019)... ... July 23, 2019 , ... ... a 100% bioactive glass synthetic biologic strip indicated for spine and orthopedic use. ... to human bone. Bioactive glass has been clinically-proven in orthopedics for over 30 ...
Breaking Biology News(10 mins):